Business Description
Labcorp Holdings Inc
NAICS : 621511
SIC : 8071
ISIN : US5049221055
Share Class Description:
LH: Ordinary SharesTotal Employee Number:
71,000Compare
Compare
Traded in other countries / regions
LH.USA0JSY.UKN6B.GermanyL1CA34.BrazilLH.Mexico Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
1988-07-07Description
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.79 | |||||
Debt-to-EBITDA | 3.14 | |||||
Interest Coverage | 7.17 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.45 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.7 | |||||
3-Year EBITDA Growth Rate | 4 | |||||
3-Year EPS without NRI Growth Rate | -16.6 | |||||
3-Year FCF Growth Rate | -4.8 | |||||
3-Year Book Growth Rate | -2.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.08 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.18 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.65 | |||||
9-Day RSI | 67.99 | |||||
14-Day RSI | 69.57 | |||||
3-1 Month Momentum % | 19.59 | |||||
6-1 Month Momentum % | 8.68 | |||||
12-1 Month Momentum % | 14.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 18.77 | |||||
Days Sales Outstanding | 55.79 | |||||
Days Payable | 26.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.86 | |||||
Dividend Payout Ratio | 0.17 | |||||
3-Year Dividend Growth Rate | 10.1 | |||||
Forward Dividend Yield % | 0.86 | |||||
5-Year Yield-on-Cost % | 0.86 | |||||
3-Year Average Share Buyback Ratio | 2.3 | |||||
Shareholder Yield % | 4.34 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.88 | |||||
Operating Margin % | 11.35 | |||||
Net Margin % | 6.99 | |||||
EBITDA Margin % | 15.04 | |||||
FCF Margin % | 8.05 | |||||
OCF Margin % | 11.42 | |||||
ROE % | 11.62 | |||||
ROA % | 5.43 | |||||
ROIC % | 8.09 | |||||
3-Year ROIIC % | 10.74 | |||||
ROC (Joel Greenblatt) % | 32.64 | |||||
ROCE % | 9.2 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 27.72 | |||||
Forward PE Ratio | 18.25 | |||||
PE Ratio without NRI | 20.24 | |||||
Shiller PE Ratio | 23.65 | |||||
Price-to-Owner-Earnings | 36.98 | |||||
PS Ratio | 1.97 | |||||
PB Ratio | 3.15 | |||||
Price-to-Free-Cash-Flow | 24.11 | |||||
Price-to-Operating-Cash-Flow | 16.97 | |||||
EV-to-EBIT | 23.15 | |||||
EV-to-Forward-EBIT | 22.56 | |||||
EV-to-EBITDA | 15.68 | |||||
EV-to-Forward-EBITDA | 15.68 | |||||
EV-to-Revenue | 2.36 | |||||
EV-to-Forward-Revenue | 2.3 | |||||
EV-to-FCF | 29.27 | |||||
Price-to-GF-Value | 1.21 | |||||
Price-to-Projected-FCF | 1.29 | |||||
Price-to-Median-PS-Value | 1.31 | |||||
Earnings Yield (Greenblatt) % | 4.32 | |||||
FCF Yield % | 4.25 | |||||
Forward Rate of Return (Yacktman) % | -6.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:LH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Labcorp Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14,348 | ||
| EPS (TTM) ($) | 12.09 | ||
| Beta | 0.4748 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.78 | ||
| Volatility % | 25.48 | ||
| 14-Day RSI | 69.57 | ||
| 14-Day ATR ($) | 7.37482 | ||
| 20-Day SMA ($) | 325.3425 | ||
| 12-1 Month Momentum % | 14.15 | ||
| 52-Week Range ($) | 244.52 - 341.795 | ||
| Shares Outstanding (Mil) | 81.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Labcorp Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Labcorp Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-24 | In 179 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-17 09:00 | In 173 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-17 | In 172 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-28 09:00 | In 61 days | ||
| Third quarter earnings results for 2026 | 2026-10-28 | In 60 days | ||
| Morgan Stanley 24th Annual Global Healthcare Conference PR Newswire | 2026-09-15 11:30 | In 18 days | ||
| Analyst meeting for 2026 | 2026-09-10 09:00 | In 13 days | ||
| USD 0.720000 Cash Dividend | 2026-08-28 | 336.54 (+0.95%) | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 09:00 | 307.15 (-1.51%) | ||
| Second quarter earnings results for 2026 | 2026-07-30 | 307.15 (-1.51%) |
Show
Entries
Labcorp Holdings Inc Frequently Asked Questions
What is Labcorp Holdings Inc(LH)'s stock price today?
The current price of LH is $335.11. The 52 week high of LH is $341.80 and 52 week low is $244.52.
When is next earnings date of Labcorp Holdings Inc(LH)?
The next earnings date of Labcorp Holdings Inc(LH) is 2026-10-28 Est..
Does Labcorp Holdings Inc(LH) pay dividends? If so, how much?
The Dividend Yield %  of Labcorp Holdings Inc(LH) is 0.86% (As of Today), Highest Dividend Payout Ratio of Labcorp Holdings Inc(LH) was 0.25. The lowest was 0.11. And the median was 0.21. The  Forward Dividend Yield % of Labcorp Holdings Inc(LH) is 0.86%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:LH
Weitz Multi Cap Equity Fund
Bullish
2026 Q1
What the manager wrote
Labcorp was one of our top contributors this quarter, delivering mid-single-digit positive returns despite an overall market decline. This performance reflects the company's resilience and strong fundamentals in the health care sector. We believe Labcorp's capabilities and market position provide a significant competitive advantage, which supports our conviction in its long-term growth potential.
Madison Mid Cap Fund
Bullish
2026 Q1
What the manager wrote
Labcorp shares outperformed as lab volume growth surprised to the upside. This indicates strong demand for their services, which positions Labcorp favorably in the current market environment. The company is benefiting from trends that favor high-quality, durable businesses, and we believe this growth trajectory will continue as the economy improves.
Press Release
Articles on Labcorp Holdings Inc
Headlines
See More- 1
Aug 24, 2026
Roche’s Alzheimer’s blood test wins FDA clearance
Seeking Alpha • 7:11am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers